About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Tuberous Sclerosis: A Diagnostic Clinical Dilemma: Review and Case Report
Priti Singh1, V. Chandar2
1Department of Pediatrics, Dr. Ram Manohar Lohia Hospital and Post Graduate Institute of Medical Education and Research, New Delhi; 2Department of Pediatrics and Neonatology, Swami Rama Himalayan Institute of Medical Sciences, Jolly Grant, Dehradun, Uttarakhand, India.
Corresponding Author:
Dr Priti Singh
Email: drpritisingh1532@gmail.com
Received: 29-JUN-2020 Accepted: 16-AUG-2020 Published Online: 25-OCT-2020
DOI: http://dx.doi.org/10.17659/01.2020.0058
Abstract
Background: Tuberous sclerosis is neuro-cutaneous, multisystem disease affecting children and adults, characterized by the formation of hamartomatous lesions in multiple organs like brain, kidney, lung, heart and skeleton system. Case Report: We hereby report a 10 year old who presented in hypertensive encephalopathy making tuberous sclerosis a diagnostic dilemma. The investigations revealed cutaneous involvement, intracranial lesion and renal lesion. Conclusion: These patients require multidisciplinary support and prolonged palliative measures for better outcome and survival.
Keywords : Angiomyolipoma, Blood Pressure, Scabies, Seizures, Tuberous Sclerosis.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025